AVI-4020

AVI-4020 · Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AVI-4020, covering 2009-07-08 to 2009-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020 [Phase 1]